Gastric cancer (GC) is the second most lethal cancer in the world with commonly diagnosed techniques such as gastroscopy, tissue biopsy, and microbial culture, which are standard methods that fail to avoid time-consuming and poor patient experience [1–5]. Thus, salivary biomarker testing has attracted increasing attention in recent years as an emerging cancer diagnostic method that is noninvasive, risk-free, and patient-acceptable [6–8]. Zhang et al. developed a ratiometric fluorescence enrichment detection platform for highly sensitive visual fluorescence detection of carcinoembryonic antigen (CEA) in saliva [9]. Zhang et al. discovered that a model established by six miRNAs in salivary exosomes was effective in differentiating patients with esophageal squamous cell carcinoma (ESCC) [10]. Amino acids in saliva in the form of both D-/L- enantiomers have gained great attention for their potential application in cancer, especially GC [11–12]. Recent researches have displayed that salivary concentrations of D-proline (D-Pro) and D-alanine (D-Ala) are significantly elevated in patients with early-stage GC (126.3-285.3 µM and 46.1-114.5 µM, respectively), which are ten times higher than that of normal subjects [13]. Meanwhile, the increase of salivary D-amino acids (D-AAs) was tightly correlated with the malignant progression of GC [14], suggesting that D-AAs is expected to be a promising biomarker for the early diagnosis, efficacy evaluation, and prognosis determination of GC.
To date, many traditional methods have been employed for the analysis of amino acids in saliva, including colorimetric methods [14], electrochemical biosensors [15], fluorescence biosensors [16], and others. Yet, these methods have their limitations, and it is demanding to develop a rapid and ultrasensitive D-AAs assay for the detection of early GC. Surface-enhanced Raman scattering (SERS) is regarded as a powerful spectroscopic analysis technique [17–20], which can rapidly and accurately detect target components in various complex samples due to high sensitivity, non-invasive detection capability and unique fingerprinting effect, making it widely applicable in the fields of chemical analysis, biosensing, and so on [21–22]. “Hot spots”, namely localized areas of space with extremely strong electromagnetic fields, play an important role in SERS enhancement [23]. The SERS signals of the small number of analyte molecules that fall into the “Hot spots” account for a high proportion of the overall measured SERS signal [24–25]. Nevertheless, fabricating metal substrates with uniform and dense “Hot spots” for sensitive and reproducible SERS detection remains a challenge. The large-scale ordered nanostructures have been found to generate uniform “Hot spots” for SERS signal enhancement while achieving excellent signal reproducibility and accurate SERS quantitative detection [26–27]. Au-coated Si nanocrown arrays (Au/SiNCA) are high-performance SERS substrates prepared by colloidal template-assisted etching of Au on Si nanocrown arrays, which are considered suitable for SERS applications owing to their exceptional uniformity and sensitivity.
Nevertheless, considering that D-AAs and L-AAs are enantiomers of each other with the same chemical formula and cannot avoid generating similar Raman signals, the direct discriminative detection of amino acid enantiomers with SERS remains difficult [28]. To be able to increase the enantioselectivity of SERS technology, novel chiral selection procedures must be implemented in order to overcome the aforementioned issues. Experimental evidence has confirmed that D-amino acid oxidase (DAAO) has the ability to specifically oxidize D-Ala and D-Pro, resulting in the production of H2O2 [29–30]. Utilizing the catalytic activity and stereoselectivity of DAAO, the chiral recognition of amino acids in real clinical samples can be easily achieved by indirectly measuring the H2O2 produced by D-AAs after the enzymatic reaction.
In this study, we designed and fabricated a 4 × 4 microporous array chip embedded with phenylboronic acid-modified Au/SiNCA to achieve high-throughput, ultrasensitive and specific measurement of D-AAs in subjects’ saliva (Fig. 1c). Firstly, Au/SiNCA arrays with periodic structures were prepared by monolayer colloidal template-assisted reactive ion etching (RIE) and Au deposition techniques (Fig. 1b). 3-mercaptophenylboronic acid (3-MPBA) as a traditional H2O2-responsive probe molecule was modified on the Au/SiNCA surface, denoted as 3-MPBA@Au/SiNCA. Lastly, the ITO glass embedded with 3-MPBA@Au/SiNCA was aligned with the designed PDMS cover to fabricate a high-throughput microporous array chip containing 16 SERS detection units. On this basis, an enzymatic reaction was designed to measure D-AAs as indicated in Fig. 1a. The natural enzyme DAAO first catalyzed the formation of H2O2 from D-AAs in saliva, followed by the reaction probe 3-MPBA underwent oxidation to become 3-HTP, leading to an elevated characteristic peak in the Raman spectrum at 882 cm− 1. Additionally, the strength of this SERS peak gradually increased as the concentration of H2O2 increased. Finally, a ratiometric SERS sensor was established to detect D-Ala and D-Pro content based on the intensity ratio between two characteristic peaks at 882 cm− 1 (response peak) and 998 cm− 1 (internal standard peak). The above-mentioned microporous array chip was effectively used for the high-throughput detection of D-AAs in saliva samples, and the ultimate clinical outcomes were in line with our anticipations. We believe that this enzymatic reaction-based ratiometric SERS assay enables simpler and faster detection of GC.